CIK 0001829802
- Emerging growth company
Faeth Therapeutics, Inc.
Sign in to watch- Ticker
- FTH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 512-200-2982
- Business address
- 701 TILLERY STREET #12 #1010, AUSTIN, TX, 78702
- Former names
- Sensei Biotherapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 12 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-08 | Peyer James Director | Conversion | +2,407,328 | 4,690,153 | ||
| 2021-02-08 | Peyer James Director | Conversion · Series AA Preferred Convertible Stock | −110,729,827 | 0 | ||
| 2021-02-08 | Peyer James Director | Conversion · Series BB Preferred Convertible Stock | −4,821,996 | 0 | ||
| 2021-02-08 | H&S INVESTMENTS I LP 10% owner | Conversion | +4,361,835 | 4,425,998 | ||
| 2021-02-08 | H&S INVESTMENTS I LP 10% owner | Conversion · Series AA Convertible Preferred Stock | −209,368,245 | 0 |
Page 20 of 20 · 385 trades